Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastroplasty | 4 | 2013 | 159 | 1.140 |
Why?
|
| Laparoscopy | 5 | 2013 | 2041 | 0.600 |
Why?
|
| Obesity, Morbid | 5 | 2021 | 1298 | 0.570 |
Why?
|
| Splenectomy | 2 | 2019 | 392 | 0.530 |
Why?
|
| Competitive Behavior | 1 | 2016 | 78 | 0.500 |
Why?
|
| Bariatric Surgery | 4 | 2021 | 1001 | 0.480 |
Why?
|
| Hernia, Hiatal | 1 | 2013 | 91 | 0.410 |
Why?
|
| Splenomegaly | 1 | 2013 | 192 | 0.410 |
Why?
|
| Withholding Treatment | 1 | 2015 | 620 | 0.350 |
Why?
|
| Gastric Bypass | 4 | 2019 | 824 | 0.330 |
Why?
|
| Gastroesophageal Reflux | 2 | 2013 | 836 | 0.320 |
Why?
|
| Weight Loss | 4 | 2021 | 2721 | 0.260 |
Why?
|
| General Surgery | 1 | 2016 | 1720 | 0.230 |
Why?
|
| Salvage Therapy | 1 | 2010 | 1273 | 0.220 |
Why?
|
| Societies, Medical | 1 | 2016 | 3968 | 0.220 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2024 | 56 | 0.220 |
Why?
|
| Clinical Competence | 2 | 2016 | 4858 | 0.210 |
Why?
|
| Intussusception | 2 | 2013 | 116 | 0.190 |
Why?
|
| Insulin | 2 | 2015 | 6607 | 0.180 |
Why?
|
| Vascular Patency | 1 | 2024 | 917 | 0.180 |
Why?
|
| Databases, Factual | 3 | 2024 | 8080 | 0.170 |
Why?
|
| Unified Medical Language System | 1 | 2019 | 89 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2017 | 12252 | 0.150 |
Why?
|
| Edema | 1 | 2022 | 765 | 0.150 |
Why?
|
| Prosthesis Design | 1 | 2024 | 2125 | 0.140 |
Why?
|
| Lipoma | 1 | 2017 | 296 | 0.120 |
Why?
|
| Liposarcoma | 1 | 2017 | 289 | 0.120 |
Why?
|
| Semantics | 1 | 2019 | 618 | 0.120 |
Why?
|
| Data Mining | 1 | 2019 | 563 | 0.110 |
Why?
|
| Inservice Training | 1 | 2016 | 375 | 0.110 |
Why?
|
| Obesity | 2 | 2019 | 13090 | 0.110 |
Why?
|
| Massachusetts | 3 | 2016 | 8890 | 0.110 |
Why?
|
| Reoperation | 3 | 2012 | 4329 | 0.100 |
Why?
|
| Stents | 1 | 2024 | 3195 | 0.100 |
Why?
|
| Adrenalectomy | 1 | 2013 | 348 | 0.100 |
Why?
|
| Endometrial Neoplasms | 1 | 2021 | 1382 | 0.090 |
Why?
|
| Faculty | 1 | 2013 | 383 | 0.080 |
Why?
|
| Alanine Transaminase | 1 | 2012 | 606 | 0.080 |
Why?
|
| Venous Thrombosis | 1 | 2019 | 1323 | 0.080 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 39348 | 0.080 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2013 | 246 | 0.080 |
Why?
|
| Remission Induction | 1 | 2015 | 2410 | 0.080 |
Why?
|
| Longitudinal Studies | 3 | 2015 | 14783 | 0.080 |
Why?
|
| Receptor, erbB-2 | 1 | 2019 | 2603 | 0.080 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2013 | 735 | 0.080 |
Why?
|
| Hyperlipidemias | 1 | 2012 | 772 | 0.070 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 2665 | 0.070 |
Why?
|
| Canada | 1 | 2012 | 2130 | 0.070 |
Why?
|
| Middle Aged | 11 | 2024 | 223492 | 0.060 |
Why?
|
| Treatment Outcome | 5 | 2024 | 65371 | 0.060 |
Why?
|
| Thrombocytopenia | 1 | 2013 | 1179 | 0.060 |
Why?
|
| Equipment Design | 1 | 2012 | 3522 | 0.060 |
Why?
|
| Body Weight | 1 | 2015 | 4627 | 0.060 |
Why?
|
| Female | 14 | 2024 | 397192 | 0.060 |
Why?
|
| Male | 12 | 2024 | 364719 | 0.050 |
Why?
|
| Retrospective Studies | 9 | 2024 | 81762 | 0.050 |
Why?
|
| Humans | 18 | 2024 | 768166 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2022 | 20760 | 0.050 |
Why?
|
| Adult | 9 | 2024 | 223646 | 0.050 |
Why?
|
| Surgical Procedures, Operative | 1 | 2013 | 1932 | 0.050 |
Why?
|
| Prospective Studies | 4 | 2013 | 54926 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2013 | 6283 | 0.040 |
Why?
|
| Length of Stay | 1 | 2013 | 6498 | 0.040 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2012 | 1899 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2015 | 22291 | 0.040 |
Why?
|
| Postoperative Complications | 2 | 2012 | 15832 | 0.040 |
Why?
|
| Prevalence | 2 | 2013 | 15869 | 0.040 |
Why?
|
| Sex Factors | 1 | 2012 | 10632 | 0.040 |
Why?
|
| Incidence | 2 | 2013 | 21538 | 0.040 |
Why?
|
| Time Factors | 2 | 2024 | 40218 | 0.040 |
Why?
|
| Comorbidity | 1 | 2012 | 10590 | 0.040 |
Why?
|
| Aged | 7 | 2024 | 171504 | 0.040 |
Why?
|
| Risk Factors | 4 | 2024 | 74944 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2013 | 5953 | 0.030 |
Why?
|
| Hypertension | 1 | 2012 | 8616 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 21206 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2024 | 59629 | 0.020 |
Why?
|
| Jejunum | 1 | 2012 | 475 | 0.020 |
Why?
|
| Endovascular Procedures | 1 | 2024 | 2216 | 0.020 |
Why?
|
| Asthma | 1 | 2007 | 6291 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2019 | 13053 | 0.020 |
Why?
|
| Hydroxycorticosteroids | 1 | 2007 | 3 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2012 | 1826 | 0.020 |
Why?
|
| Iran | 1 | 2007 | 763 | 0.010 |
Why?
|
| United States | 1 | 2012 | 73039 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2012 | 6229 | 0.010 |
Why?
|
| Leadership | 1 | 2013 | 1397 | 0.010 |
Why?
|
| Family Health | 1 | 2007 | 1255 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2013 | 5315 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 15454 | 0.010 |
Why?
|
| Young Adult | 2 | 2019 | 60066 | 0.010 |
Why?
|
| Respiratory Tract Infections | 1 | 2007 | 1014 | 0.010 |
Why?
|
| Survival Rate | 1 | 2013 | 12840 | 0.010 |
Why?
|
| Urban Population | 1 | 2007 | 2046 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 2007 | 1172 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 30010 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 89169 | 0.010 |
Why?
|
| Age Factors | 1 | 2007 | 18412 | 0.010 |
Why?
|
| Hospitalization | 1 | 2007 | 10840 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2007 | 26422 | 0.000 |
Why?
|
| Infant | 1 | 2007 | 36535 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2007 | 42669 | 0.000 |
Why?
|
| Child | 1 | 2007 | 80917 | 0.000 |
Why?
|
Concepts
(103)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(24)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_